Global /China /Healthcare /Drug Manufacturers - General /1643

Modern Chinese Medicine Group Co., Ltd.

1643

• SHEK: 1643 • Delayed

2.82HKD -4.1%

0.3597 USD

As of 24 June 2026, Modern Chinese Medicine Group Co., Ltd. has a market cap of $269.96M USD, ranking #19222 globally and #5639 in China. It ranks #1723 in the Healthcare sector, and #630 in the Drug Manufacturers - General industry.

Global Rank

19222

Country Rank

5639

Sector Rank

1723

Industry Rank

630

Key Stats

Market Cap

$269.96MUSD

2.12B HKD

Enterprise Value

$237.38MUSD

1.86B HKD

Revenue (TTM)

$20.6MUSD

161.55M HKD

EBITDA (TTM)

-$1.06MUSD

-8.34M HKD

Net Income (TTM)

-$1.92MUSD

-15.09M HKD

EBITDA Margin

-5.2%

Profit Margin

-9.3%

PS Ratio

13.1

PB Ratio

3.8

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Hongli Zhang open_in_new

Employees

189

Founded

1986

Website

cdysjdyy.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-4.1%	5%	26%	287%	326%	476%	728%	513%	230%

News

Markets

Exchange	Ticker	Price	Quotes
Hong Kong Stock Exchange (SHEK / HKEX) MIC: XHKG PRIMARY	1643 现代中药集团有限公司 Ordinary Shares ISIN: KYG6181B1068 Shares Out.: Shares Outstanding: 720.0M¹ Shares Float: 180.0M² TV: TradingView: HKEX: 1643 SA: Stock Analysis: HKG: 1643 YF: Yahoo Finance: 1643.HK GF: Google Finance: HKG: 1643 BA: Barron's: 1643 MS: Morningstar: XHKG: 01643	2.82 HKD	TV: TradingView: HKEX: 1643 SA: Stock Analysis: HKG: 1643 YF: Yahoo Finance: 1643.HK GF: Google Finance: HKG: 1643 BA: Barron's: 1643 MS: Morningstar: XHKG: 01643

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Modern Chinese Medicine Group Co., Ltd.

Modern Chinese Medicine Group Co., Ltd., an investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China. It provides vigour and vitality supplement, circulation enhancement pills, cardiotonic enhancement capsules, heart wellness capsules, menstrual discomfort relief, liver detox tablets, liver-dispersing and stomach regulating pills, fever- removing and detoxification pills, kidney invigoration pills, and huoxiang zheng qi pills. The company offers its products as therapeutics for the treatment of qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, and for symptoms of COVID-19 and similar illnesses. It also provides business support, technical, and consulting services. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. operates as a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.79B 364.89B CNY 20K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.58B 336.36B CNY 18K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.5B 223.48B HKD 10K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.79B 147.32B HKD 7K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.49B 111.89B CNY 6K%	-	China
Akeso, Inc. SHEK: 9926	$16.0B 125.46B HKD 6K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 282K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 203K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 133K%	97.4	United States
Roche Holding AG SIX: RO	$316.37B 256.25B CHF 117K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.33B 215.59B GBP 105K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 101K%	15.1	United States

chevron_leftBack